4th Quarter - Termination

W STRATEGIES, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—
Terminated
Dec 31, 2021

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures 2.0. H.R.5376: Build Back Better Act as it relates to H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, H.R.19. Lower Costs, More Cures Act of 2021 and Orphan Drug Tax Credit.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), H.R. 19 (117th), H.R. 3 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.